Beijing Strong Biotechnologies Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Strong Biotechnologies Inc with three other
companies in this sector in China:
Getein Biotech Inc
sales of 488.58 million Chinese Renmimbi [US$72.12 million]
of which 99%
was In-vitro diagnostics),
Beijing Leadman Biochemistry Co Ltd
(575.98 million Chinese Renmimbi [US$85.03 million]
of which 100%
was Biological products industry), and
Guangdong Hybribio Biotech Co Ltd
(479.09 million Chinese Renmimbi [US$70.72 million]
of which 97%
was Monitoring Instrument).
Beijing Strong Biotechnologies Inc reported sales of 694.28 million Chinese Renmimbi (US$102.49 million)
December of 2017.
increase of 4.0%
versus 2016, when the company's sales were 667.39 million Chinese Renmimbi.
Sales at Beijing Strong Biotechnologies Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 83%).